Shkreli Keeps Fighting 'Needlessly Crushing' Penalties

By Bryan Koenig · April 14, 2023, 6:17 PM EDT

Martin Shkreli pressed the Second Circuit on Thursday to overturn his $64.6 million fine and lifetime pharmaceutical industry ban imposed through a Federal Trade Commission and attorneys general antitrust case, arguing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Federal Trade Commission v. Vyera Pharmaceuticals, LLC

Case Number

Court

Appellate - 2nd Circuit

Nature of Suit

2430 STATUTES-Banks & Banking

Date Filed

April 07, 2022

Recent Articles By Bryan

July 31, 2024
Inhaler Patents 'Must Be' In Orange Book, Teva Tells Fed. Circ.
July 17, 2024
Heart Doctor's Sham Suit Claims Cut From Antitrust Row
July 11, 2024
Fed. Circ. Pauses Ouster Of Teva Patents From Orange Book
July 08, 2024
Texas Anesthesia Co. Can't Pause Or Appeal Suit, FTC Says
June 27, 2024
EU High Court Upends Servier Decrease Of Pay-For-Delay Fine
June 26, 2024
Apple Watch Improvement Is 'Inferior,' Docs Tell 9th Circ.
June 13, 2024
EU Makes First Ever Formal Pharma Price-Fixing Complaint
June 12, 2024
Texas Anesthesia Co. Appealing To Duck FTC Suit To 5th Circ.
June 10, 2024
Rehab Clinics Add To MultiPlan Insurance Fixing Pile-On
May 22, 2024
Teva, Bristol-Myers Cite Bystolic Against Cancer Drug Case